The Lung Cancer Consortium Singapore (LCCS) was established in 2001, with the aim to bring together the clinical and research community in order to advance the diagnosis and management of thoracic cancers.. All disciplines involved in study and care of lung cancer patients are invited to participate – including public health practitioners and researchers, respiratory physicians, thoracic surgeons, radiologists, pathologists, scientists, radiation oncology, medical oncology and allied health. Both public and private sector clinicians across all hospitals collaborate with research institutions in Singapore in order to better understand the origins of lung cancer, as well as introduce improved interventions and novel therapies for cancer patients.
Through this multidisciplinary network, a repository of curated bio specimens with relevant clinical data has been established. The translational platform has been possible through institutional support, academic and industry grants and philanthropy.